Clinical Trial Update: Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and efficacy of latanoprost liposome for lower eyelid steatoblepharon has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Eyelid Steatoblepharon

Drugs mentioned

• Latanoprost liposome (latanoprost liposome)

Snippet

Sponsor: Peregrine Ophthalmic | Conditions: Lower Eyelid Steatoblepharon | Phase 1 | Status: COMPLETED